Insulin-free times

[Guest guest]

Insulin-FreeTIMES (IFT), a quarterly eMagazine published by Diabetes Portal,

provides current information about therapies, research and advanced clinical

studies aimed at curing diabetes. Our Spring 2005 Issue, which focuses on the

worldwide effort of finding a cure for diabetes, is now online at

http://www.InsulinFreeTimes.org/

__________________________________

IN THIS ISSUE:

__________________________________

From Australia:

THE HOPE OF HUMAN EMBRYONIC STEM CELLS

AS A THERAPY FOR DIABETES

http://www.insulinfreetimes.com/05_spring/tuch.htm

Dr. Bernie Tuch, Director, Diabetes Transplant Unit, Prince of Wales Hospital

in Sydney gives a global view of the progress of human embryonic stem cell

research.

__________________________________

From Europe:

THE IMPACT OF ISLET TRANSPLANTATION ON

CARDIOVASCULAR COMPLICATIONS OF DIABETES

http://www.insulinfreetimes.com/05_spring/secchi.htm

Dr. Secchi from the San Raffeale Institute in Milan, Italy presents a

study on the improvements of cardiovascular disease following islet

transplantation. This work documents that secondary complications from diabetes

can improve with the regulation of blood glucose levels through islet

transplantation.

__________________________________

From the world at large:

HELP US TO IMPROVE INSURANCE COVERAGE

http://www.insulinfreetimes.org/05_spring/survey.htm

Diabetes Portal is conducting a survey to calculate the extent of complications,

type of management, and general health of people with diabetes and we need your

help! We hope to show that aggressive therapy through transplantation or

insulin pump therapy is cost effective for insurance companies and the federal

government. Please take a few minutes to complete this survey, and possibly win

a $1,000 in the process!

__________________________________

From North America:

LEVERAGING DEDICATION WITH PUBLIC AND

PRIVATE SUPPORT TO CURE DIABETES

http://www.insulinfreetimes.org/05_spring/fish.htm

The Diabetes Institute of Immunology and Transplantation (DIIT) at the

University of Minnesota has a long history of advancing the treatment of type 1

diabetes. Dawn Fish, Director of Development at the DIIT provides an account of

the progress of research in Minnesota and how fundraising is key to their

success.

__________________________________

From the Middle East:

SURROGATE BETA CELLS FROM TISSUE STEM CELLS

http://www.insulinfreetimes.org/05_spring/efrat.htm

Dr. Shimon Efrat of the University of Tel Aviv in Israel discusses his work in

beta cell replacement through manipulation of pluripotent tissue cells. This

comprehensive report explains the different avenues being taken in the

laboratory to expand the supply of insulin producing cells.

__________________________________

From around the globe:

IMMUNOSUPPRESSION FOR ISLET AND

PANCREAS TRANSPLANTATION

http://www.insulinfreetimes.org/05_spring/immuno.htm

Rapa, MMF, CsA, OKT3 -- do you get confused by the alphabet soup that you hear

when people are discussing immunosuppression? This article clarifies the

terminology, discusses side-effects associated with immunosuppression drug

today, and looks at some of the drugs being developed for the future.

__________________________________

From Italy:

PANCREAS TRANSPLANTATION ALONE TO TREAT TYPE 1 DIABETES

http://www.insulinfreetimes.org/05_spring/marchetti.htm

Dr. Piero Marchetti of the University of Pisa, Italy gives a summary of four

years of experience with pancreas transplant alone procedures (PTA). PTA has

become a clinically relevant option in patients with type 1 diabetes without

advanced nephropathy. It restores normoglycemia in the vast majority of patients

and has a positive impact on late diabetic complications.

__________________________________

Editorial from South America:

GRINGO LOCO SHOOTING IT UP IN THE SOUTH

http://www.insulinfreetimes.org/05_spring/editorial.htm

This article gives a personal and vivid view of problems encountered by people

with type 1 diabetes in South America and an opinion on what may be needed to

alleviate the financial and medical supply difficulties that are rampant in this

part of the world.

__________________________________

Editorial from The United States:

WHY BIG PHARMACEUTICAL COMPANIES' CURRENT

NANOTECH EFFORTS SHOULD FAIL

http://www.insulinfreetimes.org/05_spring/strumello.htm

A view on the policies of large pharmaceutical companies and the hope of a new

trend in research that might be the key to a better therapy for people with

diabetes.

__________________________________

REGULAR FEATURES:

__________________________________

DP NEWS

http://www.insulinfreetimes.org/05_spring/dpnews.htm

WHY WE NEED A CURE

http://www.insulinfreetimes.org/05_spring/why.htm

PEOPLE AND PLACES

http://www.insulinfreetimes.org/05_spring/pandp.htm

eBYTES FROM DISCUSSIONS ON DIABETES STATION

http://www.insulinfreetimes.org/05_spring/ebytes.htm

__________________________________

Insulin-FreeTIMES

www.InsulinFreeTimes.com

Email: Editor@...

To SUBSCRIBE to IFT, go to www.DiabetesPortal.com/registration